Circulation

FEBRUARY 26, 2024

Cardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates of 30% to 50% despite recent scientific advances. Age is a nonmodifiable risk factor for mortality in patients with cardiogenic shock and is often considered in the decision-making process for eligibility for various therapies.

Cardiogenic Shock 74

Cardiogenic Shock Best Practices Heart Transplant Transplant 74

Journal of Cardiothoracic Surgery

AUGUST 23, 2024

Fulminant myocarditis has been defined as the clinical manifestation of cardiac inflammation with rapid-onset heart failure and cardiogenic shock. We report on the case of a 17-year-old boy with hemodynamic de.

Cardiogenic Shock 52

Cardiogenic Shock Heart Transplant Transplant Heart Failure 52

Frontiers in Cardiovascular Medicine

MAY 2, 2024

Eosinophilic myocarditis (EM), a rare condition, is fatal if left untreated and has rarely been described in heart transplant recipients. We have described the case of a 17-year-old heart transplant recipient who presented with a cardiogenic shock.

Heart Transplant 52

Heart Transplant Transplant Cardiogenic Shock Heart Failure 52

DAIC

APRIL 8, 2024

milla1cf Mon, 04/08/2024 - 18:07 April 8, 2024 — Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly increased the rate of survival at six months among people suffering cardiogenic shock, according to a study presented at the American College of Cardiology ’s Annual Scientific Session.

Heart Attack 52

Heart Attack Heart attacks Cardiogenic Shock Catheterization Laboratory 52

Circulation: Heart Failure

MARCH 8, 2024

Centers performing at least 1 heart transplant or left ventricular assist device were classified as ATCs. A secondary analysis evaluated outcomes for severe HF hospitalizations (cardiogenic shock, cardiac arrest, and mechanical ventilation). of centers), 525 037 (18.3%) were admissions to ATCs (5.5%

Heart Failure 40

Heart Failure Cardiogenic Shock Outcomes Cardiac Arrest 40

Frontiers in Cardiovascular Medicine

MARCH 3, 2024

In a cohort of 224 patients with SCAI Stage C shock requiring milrinone initiation, a baseline MPS score of <0.5 was associated with a 35% event rate of the composite endpoint of death, left ventricular assist device, or transplant at 30 days compared with 3% for those with an MPS >1 ( p  < 0.001).

Heart Failure 85

Heart Failure Cardiogenic Shock Physiology Transplant 85

Dr. Smith's ECG Blog

OCTOBER 26, 2010

This 54 year old patient with a history of kidney transplant with poor transplant function had been vomiting all day when at 10 PM he developed severe substernal crushing chest pain. ACS and STEMI generally do not cause tachycardia unless there is cardiogenic shock. He had this ECG recorded. Are the lungs clear?

STEMI 52

STEMI Cardiogenic Shock Tachycardia Aneurysm 52